RecruitingNot ApplicableNCT06362733

Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth


Sponsor

Stanford University

Enrollment

44 participants

Start Date

Jul 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this open label trial is to examine the preliminary feasibility, acceptability, and effectiveness of a 12-week behavioral intervention program (1 hour/week) to treat insistence on sameness (e.g., difficulty tolerating changes in routine) in youth with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of a combination of parent-training and parent-mediated intervention with the child.


Eligibility

Min Age: 4 YearsMax Age: 17 Years

Inclusion Criteria7

  • Participants will include children with:
  • parent/guardian aged 18 years or older with a child aged between 4.0 to 17.11 years old at the time of parental consent;
  • diagnosed with ASD (based on history, review of available medical records including diagnostic testing, e.g., ADOS) or suspicion of ASD diagnosis and confirmed with Autism Diagnostic Interview-Revised (ADI-R);
  • parent-reported clinically significant concerns regarding insistence on sameness and behavioral inflexibility;
  • stable behavioral and pharmacological treatment for at least two weeks with no anticipated changes;
  • English-speaking parent and youth able to consistently participate in study procedures;
  • family resides in United States.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALModified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth

This is a 12-week intervention program (1 hour/week) of treatment to target insistence on sameness in youth with autism spectrum disorder (ASD). Treatment will be delivered via secure telemedicine platform and consist of combination of parent-training and parent-mediated intervention with the child.


Locations(1)

401 Quarry Road (Remote Study)

Stanford, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06362733


Related Trials